A robust DACH session at HBI 2019 reached broad agreement over the most - and least - favourable areas for investment in healthcare in the region, but struggled to agree on the likely implication of the key legislation about to be brought in.
In March, a small French medtech supplier revealed it was to acquire an unnamed group with hospital assets in Colombia and Africa with over €70m in revenue. HBI can exclusively reveal the name of that group.
The health insurer for Portugal's 1.2 million civil servants says it will soon announce its new price list for services rendered by the country's private hospitals, the biggest of which briefly cut ties with the body at the start of 2019. We talk to one of their executives.
Private Healthcare Information Network (Phin) has published data on consultant physician fees in the private sector in the UK for the first time. So how close are we to really clear comparisons on price and quality between for-profit operators and on quality between the for-profit and NHS?
How is Europe's largest private equity invested market faring in these uncertain times, as staff shortages and the continuing uncertainty of Brexit make forecasting the future difficult? In most cases, better than you might think! This was the general response from HBI 2019's learned panel of UK and Ireland experts - but as always there were exceptions that proved the rule.
Brazilian payor-provider Amil, owned by UnitedHealth, has partially or fully de-listed almost half of Rede D'Or's hospitals, the country's largest operator, while its president talks about "not referring patients to anyone who is wasting money". One local source thinks this is the beginning of a massive tussle between the two giants, while another says their size makes a swift compromise inevitable.
HBI reports from the Sub-Saharan Africa panel at HBI 2019, where Teo Sarda, CEO of Sphera, Dr Shrey Viranna, CEO of Life, and Audrey Obara, head of healthcare for Swedfund, talked about how to sustainably invest in Africa.
Deloitte is starting to launch an array of healthcare assets, as well as acting as an adviser. Is this a move into operations management? HBI speaks to Sara Siegel, head of healthcare at Deloitte UK.
Healthcare operators do not, generally, find procurement a hot topic – yet there are huge savings to be made and procurement done well can make a substantial difference to a company’s bottom line. Where is the booking.com of medtech, and why do companies seem content to pay up to fivefold more for the same product in a neighbouring country? How do you get operators interested in procurement when. Clearly, if they can save money they ought to be?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.